HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

AbstractBACKGROUND:
Androgen suppression treatment (AST) might increase the risk of cardiac morbidity in prostate cancer patients. Possible explanations were provided, however, they disregard the potential contribution of prophylactic radiotherapy to the mamillary regions (PMRT, prescribed to avoid gynecomastia).
METHODS:
We studied the exposure of the heart in a typical electron beam PMRT setting by evaluating computed tomography (CT) scans in 40 non-cancer patients (age 65 and 75 years in 50% each) and 17 prostate cancer patients. Five of the younger, 7 of the older and 4 of the cancer patients had significant cardiac disease.
RESULTS:
The median distance between skin and outer heart contour decreased with age. In all three groups, patients with cardiac morbidity had smaller distances. When using the CT-determined PMRT beam energy, 10% of the younger, 15% of the older and none of the prostate cancer patients would receive approximately 50% of the prescription dose to a part of the heart (2 had no history of cardiac disease). When using the clinically rather than CT-determined beam energy, as often done in daily practice, an additional 12.5% of the non-cancer and 12% of the prostate cancer patients would be exposed to comparably high doses.
CONCLUSION:
The present data provide preliminary evidence that PMRT might be a factor that contributes to cardiac side effects. Previous studies that established a relationship between AST and cardiac morbidity did not include information on delivery of PMRT.
AuthorsCarsten Nieder, Adam Pawinski, Nicolaus H Andratschke, Michael Molls
JournalRadiation oncology (London, England) (Radiat Oncol) Vol. 3 Pg. 2 (Jan 10 2008) ISSN: 1748-717X [Electronic] England
PMID18186924 (Publication Type: Journal Article)
Chemical References
  • Androgen Antagonists
Topics
  • Aged
  • Aged, 80 and over
  • Androgen Antagonists (adverse effects)
  • Breast (radiation effects)
  • Gynecomastia (prevention & control)
  • Heart (drug effects, radiation effects)
  • Heart Diseases (etiology)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy)
  • Radiotherapy (adverse effects)
  • Radiotherapy Dosage
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: